- Home
- RAYA vs CALC Comparison
RAYA vs CALC Comparison
Compare RAYA & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAYA
- CALC
- Stock Information
- Founded
- RAYA 2019
- CALC 2011
- Country
- RAYA China
- CALC United States
- Employees
- RAYA N/A
- CALC N/A
- Industry
- RAYA Metal Fabrications
- CALC Biotechnology: Pharmaceutical Preparations
- Sector
- RAYA Consumer Discretionary
- CALC Health Care
- Exchange
- RAYA Nasdaq
- CALC Nasdaq
- Market Cap
- RAYA 35.8M
- CALC 40.3M
- IPO Year
- RAYA 2022
- CALC N/A
- Fundamental
- Price
- RAYA $1.30
- CALC $3.07
- Analyst Decision
- RAYA
- CALC Strong Buy
- Analyst Count
- RAYA 0
- CALC 5
- Target Price
- RAYA N/A
- CALC $18.20
- AVG Volume (30 Days)
- RAYA 24.2K
- CALC 25.7K
- Earning Date
- RAYA 01-01-0001
- CALC 11-13-2024
- Dividend Yield
- RAYA N/A
- CALC N/A
- EPS Growth
- RAYA N/A
- CALC N/A
- EPS
- RAYA N/A
- CALC N/A
- Revenue
- RAYA $22,816,585.00
- CALC N/A
- Revenue This Year
- RAYA $64.53
- CALC N/A
- Revenue Next Year
- RAYA $9.61
- CALC N/A
- P/E Ratio
- RAYA N/A
- CALC N/A
- Revenue Growth
- RAYA N/A
- CALC N/A
- 52 Week Low
- RAYA $0.50
- CALC $2.05
- 52 Week High
- RAYA $1.78
- CALC $8.38
- Technical
- Relative Strength Index (RSI)
- RAYA 53.16
- CALC 49.36
- Support Level
- RAYA $1.13
- CALC $2.73
- Resistance Level
- RAYA $1.47
- CALC $3.22
- Average True Range (ATR)
- RAYA 0.16
- CALC 0.30
- MACD
- RAYA -0.01
- CALC 0.01
- Stochastic Oscillator
- RAYA 48.57
- CALC 40.00
About RAYA Erayak Power Solution Group Inc.
Erayak Power Solution Group Inc engages in manufacturing, research and development, and wholesale and retail of power solution products. Its product portfolio includes sine wave and off-grid inverters, inverter and gasoline generators, battery, and smart chargers, and custom-designed products. It derives the majority revenue from three products namely inverters, chargers, and gasoline generators. The company geographically operates in China, Australia, Poland, U.K., and Germany. It derives maximum revenue from China.
About CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need. Its proprietary technology targets the inhibition of calcium release-activated calcium channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases for which there are no approved therapies.